Skip to main content

The chief medical advisor at the Muscular Dystrophy Association spoke on the specific safety considerations clinicians should take when prescribing and administering gene therapy for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]:

Source: Neurology Read More